Sunday, 3 Mar 2024

Pre-market Movers: BIOR, HCDI, MINM, ALT, SMFL…

PagerDuty, Inc. Q3 Earnings Summary

Below are the earnings highlights for PagerDuty, Inc. (PD):

Earnings: -$15.1 million in Q3 vs. -$32.5 million in the same period last year.
EPS: -$0.16 in Q3 vs. -$0.36 in the same period last year.
Excluding items, PagerDuty, Inc. reported adjusted earnings of $19.2 million or $0.21 per share for the period.

Analysts projected $0.14 per share
Revenue: $108.7 million in Q3 vs. $94.2 million in the same period last year.

-Guidance:
Next quarter EPS guidance: $0.14 – $0.15
Next quarter revenue guidance: $109.5-$111.5 mln
Full year EPS guidance: $0.72-0.73
Full year revenue guidance: $429.0-$431.0 mln

Swiss Re Announces New Financial Targets For 2024

Ahead of its transition from US GAAP to the IFRS accounting standard, Swiss Re announced new financial targets for 2024.

The company noted that the new accounting basis will have a positive impact on the bottom line by better reflecting Life & Health Reinsurance or L&H Re’s earnings power, and on its balance sheet by eliminating systemic accounting mismatches under US GAAP. As a result, the shareholders’ equity position will be significantly higher.

The Group targets an IFRS net income of more than US$3.6 billion, and a multi-year IFRS return on equity (ROE) of more than 14% for 2024.

Life & Health Reinsurance targets a net income of US$1.5 billion for 2024.

The company maintained its capital management priorities, with the aim of returning to sustainable dividend growth.

Capgemini CFO Carole Ferrand Steps Down, Backs Annul Guidance

Capgemini (CGEMY.PK,CAPP) said on Friday that its Chief Financial Officer, Carole Ferrand, is stepping down to pursue other career opportunities.

Subsequently, the company has appointed, Nive Bhagat, as CFO with effect from January 1, 2024.

Since 2019, Bhagat has been CEO of Capgemini’s Cloud & Infrastructure Services, a global business unit.

Prior to this, from 2016, she was Head of Cloud Infrastructure Services UK and Europe.

From 2010 to 2015, Bhagat held various positions at Capgemini.

In addition, Capgemini has reaffirmed its annual outlook. For the full year, the company still expects a revenue growth of 4 percent to 7 percent, with operating margin of 13 percent to 13.2 percent.

Chicago Business Activity Expands For First Time In Over A Year

A report released by MNI Indicators on Thursday showed Chicago-area business activity unexpectedly expanded for the first time in over a year in the month of November.

MNI Indicators said its Chicago business barometer surged to 55.8 in November from 44.0 in October, with a reading above 50 indicating growth. Economists had expected the index to inch up to 45.4.

The Chicago business barometer saw its biggest monthly increase since September of 2020, returning to expansionary territory for the first time since August 2022.

MNI Indicators said the new orders index spiked by 12.5 points, driven by an increase in demand by respondents.

The production index also surged by 15.9 points, as the number of respondents reporting ‘higher’ production was the greatest since May 2021.

The inventories and supplier deliveries indexes also increased to levels above 50, while the employment index moved further above 50, reaching the highest level since July 2022.

The report also said the prices paid index edged down by 0.2 points to 59.9, below levels seen for the majority of the last three calendar years.

Caffyns HY Profit Down – Quick Facts

Caffyns plc (CFYN), a motor vehicle retailer in the south-east of the United Kingdom, reported that its profit for the six months ended 30 September 2023 declined to 30 thousand pounds or 1.1 pence per share from 1.27 million pounds or 46.4 pence per share in the prior year.

Profit before tax for the period was 44 thousand pounds, down from 1.56 million pounds in the previous year.

Underlying earnings per share were 7.0 pence compared to 46.6 pence per share in the prior year.

Revenue for the period increased by 13% to 134.3 million pounds from the prior year, primarily due to improved levels of new car sales as supply constraints from the company’s manufacturers eased.

The company has declared an interim dividend of 5.0 pence per ordinary share. The dividend will be paid on 12 January 2024 to shareholders on the register at close of business on 15 December 2023.

The company noted that its board remains cautious for the second half of the financial year.

The company said it remains confident in the longer-term prospects for the company.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Pre-market Movers: BIOR, HCDI, MINM, ALT, SMFL…

The following are some of the stocks making big moves in Friday’s pre-market trading (as of 04.50 A.M. ET).

In the Green

Biora Therapeutics, Inc. (BIOR) is up over 55% at $1.93.
Harbor Custom Development, Inc. (HCDI) is up over 39% at $1.20.
Altimmune, Inc. (ALT) is up over 34% at $4.24.
Elastic N.V. (ESTC) is up over 20% at $96.86.
ShiftPixy, Inc. (PIXY) is up over 20% at $10.03.
Samsara Inc. (IOT) is up over 19% at $32.85.
Petros Pharmaceuticals, Inc. (PTPI) is up over 17% at $1.88.
UiPath Inc. (PATH) is up over 13% at $22.40.
GigaCloud Technology Inc. (GCT) is up over 12% at $10.89.
Alithya Group Inc. (ALYA) is up over 12% at $1.24.
Ulta Beauty, Inc. (ULTA) is up over 11% at $474.01
TeraWulf Inc. (WULF) is up over 6% at $1.24.

In the Red

Minim, Inc. (MINM) is down over 37% at $2.81.
Smart for Life, Inc. (SMFL) is down over 33% at $1.61.
Incannex Healthcare Limited (IXHL) is down over 32% at $5.38.
Ampio Pharmaceuticals, Inc. (AMPE) is down over 27% at $4.20.
Aditxt, Inc. (ADTX) is down over 18% at $3.25.
Vivos Therapeutics, Inc. (VVOS) is down over 15% at $20.60.
RedHill Biopharma Ltd. (RDHL) is down over 15% at $1.70.
Ensysce Biosciences, Inc. (ENSC) is down over 11% at $1.01.
Seelos Therapeutics, Inc. (SEEL) is down over 10% at $1.13.
Cartesian Therapeutics, Inc. (RNAC) is down over 9% at $1.22.
MorphoSys AG (MOR) is down over 8% at $6.23.
Clearmind Medicine Inc. (CMND) is down over 7% at $3.24.
BioVie Inc. (BIVI) is down over 7% at $1.67.

Related Posts